A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual.


Journal

Journal of the American Academy of Child and Adolescent Psychiatry
ISSN: 1527-5418
Titre abrégé: J Am Acad Child Adolesc Psychiatry
Pays: United States
ID NLM: 8704565

Informations de publication

Date de publication:
09 2019
Historique:
received: 08 01 2018
revised: 02 01 2019
accepted: 18 01 2019
pubmed: 16 2 2019
medline: 24 7 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

This single-blind, randomized, multisite, intent-to-treat study was designed to replicate and extend Dawson et al.'s (Pediatrics. 2010;125: e17-e23) randomized controlled trial testing the effects of the Early Start Denver Model (ESDM), an intensive play- and routines-based intervention delivered in natural settings. A randomized controlled trial was conducted at 3 universities. One hundred eighteen children 14 to 24 months old with autism spectrum disorder were enrolled and randomly assigned to ESDM or community interventions for 27 months. Eighty-one children completed the full treatment course and all assessments; data from all 118 children were used in analyses. Children assigned to the ESDM intervention received 3 months of weekly parent coaching followed by 24 months of 15 hour per week (on average) 1:1 treatment weekly on average in homes or daycare settings from supervised therapy assistants while parents received coaching 4 hours monthly from a certified ESDM therapist. For the primary analyses, there were time-by-group and time-by-group-by-site interactions for language outcome. In the significant 3-way interaction involving site, 2 sites showed a significant ESDM advantage and the third site showed no significant group differences. In the planned 2-way analysis that pooled data across all 3 sites, there was a significant advantage found for the ESDM group. For the secondary analyses, there were no significant differences between the ESDM and community groups involving developmental quotient, autism severity, or adaptive behavior. The treatment effect of group on language outcomes was not moderated by baseline developmental quotient, autism severity, or language. Results of the primary analysis provide a partial replication of Dawson et al.'s 2010 language findings. Intensive Intervention for Toddlers with Autism; https://clinicaltrials.gov/; NCT00698997.

Identifiants

pubmed: 30768394
pii: S0890-8567(19)30044-9
doi: 10.1016/j.jaac.2019.01.004
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT00698997']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-865

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH081757
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Sally J Rogers (SJ)

University of California, Davis, MIND Institute, Sacramento. Electronic address: sjrogers@ucdavis.edu.

Annette Estes (A)

University of Washington, Seattle.

Catherine Lord (C)

Weill Cornell Medicine, Cornell University, New York, NY.

Jeff Munson (J)

University of Washington, Seattle.

Marie Rocha (M)

University of California, Davis, MIND Institute, Sacramento.

Jamie Winter (J)

Weill Cornell Medicine, Cornell University, New York, NY.

Jessica Greenson (J)

University of Washington, Seattle.

Costanza Colombi (C)

University of Michigan, Ann Arbor.

Geraldine Dawson (G)

Duke University, Durham, NC.

Laurie A Vismara (LA)

University of California, Davis, MIND Institute, Sacramento.

Catherine A Sugar (CA)

University of California, Los Angeles.

Gerhard Hellemann (G)

University of California, Los Angeles.

Fiona Whelan (F)

University of California, Los Angeles.

Meagan Talbott (M)

University of California, Davis, MIND Institute, Sacramento.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH